NCT07007520撤回1 期
An Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 入组人数
- 38
- 试验地点
- 2
- 主要终点
- AUC-last
研究概览
简要总结
This study will evaluate the food effect on the pharmacokinetics of DA-5223 in healthy adult subjects
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adult male or female, 19 years to 55 years
- •Male weighing 50 kg or more, female weighing 45 kg or more with a body mass index (BMI) of 18.0 kg/m2 to 30.0 kg/m2
- •The subjects signed and dated informed consent form after hearing a detailed explanation of the study, fully understanding and determined voluntarily to participate
排除标准
- •The subjects with acute illness
- •The subjects with a history of gastrointestinal disease or surgery that may affect the absorption of Investigational Product
- •The subjects hypersensitive to any of the Investigational Product components or other drug components
- •The subjects who have continuously consumed excessive smoking or alcohol within 6 months of screening, or who cannot stop smoking, caffeine, or alcohol intake during hospitalization
- •The subjects who are pregnant or lactating
研究组 & 干预措施
Sequence A
Experimental
干预措施: DA-5223(Fasting) (Drug)
Sequence A
Experimental
干预措施: DA-5223(Fed) (Drug)
Sequence B
Experimental
干预措施: DA-5223(Fasting) (Drug)
Sequence B
Experimental
干预措施: DA-5223(Fed) (Drug)
结局指标
主要结局
AUC-last
时间窗: 0~12 hours
Area under the plasma concentration-time curve up to the last measurable concentration
Cmax
时间窗: 0~12 hours
Peak Plasma Concentration
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
尚未招募
1 期
To Evaluate Effect of Food of DA-5222 in Healthy Adult SubjectsNCT06993168Dong-A ST Co., Ltd.32
尚未招募
1 期
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult SubjectsNCT06993181Dong-A ST Co., Ltd.48
已完成
1 期
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy SubjectsHealthy VolunteerNCT04204629Hanmi Pharmaceutical Company Limited25
Unknown
不适用
Pharmacokinetic Study for Anti-tuberculosis DrugsPulmonary TuberculosisNCT00948077Taipei Medical University WanFang Hospital16
已完成
1 期
A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution FormulationHealthyNCT00601432Johnson & Johnson Pharmaceutical Research & Development, L.L.C.24